CervoMed (CRVO) Common Equity (2010 - 2026)
CervoMed (CRVO) recorded Common Equity of $22.96 million in Q2 2026, down 31.3% from $33.44 million a year earlier but up 116.3% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, CervoMed reported Common Equity of $18.22 million, down 53.5% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $39.2 million in FY2024 (+431.4%), $7.38 million in FY2023, -$33.29 million in FY2022 and -$27.94 million in FY2021.
- Quarterly Common Equity has ranged from -$35.11 million in Q2 2023 to $49.98 million in Q2 2024 over the past five years.
- On a year-over-year basis, Common Equity has declined for five consecutive quarters, with growth averaging 140.9% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 549.0% in Q1 2025, against a decline of 69.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.62 million (Q1 2026), $18.22 million (Q4 2025) and $26.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | CervoMed | 14.36 Mn | -71.66 Mn | - | 22.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.96 Mn |
| Mar 31, 2026 | 10.62 Mn |
| Dec 31, 2025 | 18.22 Mn |
| Sep 30, 2025 | 26.01 Mn |
| Jun 30, 2025 | 33.44 Mn |
| Mar 31, 2025 | 34.63 Mn |
| Dec 31, 2024 | 39.20 Mn |
| Sep 30, 2024 | 45.64 Mn |
| Jun 30, 2024 | 49.98 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Sep 30, 2023 | 9.57 Mn |
| Jun 30, 2023 | -35.11 Mn |
| Mar 31, 2023 | -33.75 Mn |
| Dec 31, 2022 | -33.29 Mn |
| Sep 30, 2022 | -31.84 Mn |
| Jun 30, 2022 | -31.04 Mn |
| Mar 31, 2022 | 30.62 Mn |
| Dec 31, 2021 | -27.94 Mn |
| Sep 30, 2021 | 38.13 Mn |
API Access
CervoMed Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();